Dominant form of heart failure caused by metabolic-immune interaction, review article suggests

heart failure
Credit: Pixabay/CC0 Public Domain

The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional interaction between the body's response to metabolic stress and the immune system, according to a review article written by UT Southwestern researchers and colleagues. The article, published in Nature Cardiovascular Research, argues for more research into this root cause to develop truly effective treatments.

"Heart failure with preserved ejection fraction affects millions of people around the globe, but we currently have little to offer these patients because the mechanisms behind it have been unknown. It's been called the single greatest unmet need in cardiovascular medicine," said the article's senior author Joseph Hill, M.D., Ph.D., Professor of Internal Medicine and Molecular Biology and Chief of Cardiology at UT Southwestern. "We now have insight into this condition that we didn't have even five years ago, observations that could lead to viable clinical targets."

Dr. Hill explained that —the heart's inability to effectively pump blood—comes in two broad types: heart failure with reduced ejection fraction (HFrEF), in which the amount of blood that leaves the heart with each beat declines, and heart failure with preserved (HFpEF), in which the heart is unable to fill with blood to capacity. While HFrEF has long been the most common form, HFpEF—which is associated with obesity, diabetes, and other components of metabolic syndrome—has grown in prevalence over the last several decades and overtaken HFrEF as the most common form.

Numerous treatments exist for various types of HFrEF, but these interventions have no discernible effect on HFpEF. This is because the two conditions are caused by different underlying mechanisms, said Dr. Hill, a topic that his lab has studied for years. Although HFpEF can be improved through , losing weight is something that many individuals struggle with, he added, prompting the need for treatments.

In the review article, Hill and his colleagues outline findings made over the past several years that point to joint metabolic and immune dysfunction as the root cause of HFpEF. For example, secretes inflammatory molecules that migrate to the heart, recruiting evident in heart biopsy samples from individuals with HFpEF. At the same time, heart toxicity caused by overuse of fatty acids as fuel in individuals with metabolic syndrome appears to stimulate an immune response, leading to a .

Crosstalk between fat tissue, the , and the heart appears to amplify both immune and , ultimately causing the heart to fail over time. But how this crosstalk occurs, the effects it produces, and how to block them remain unclear, Dr. Hill said. Research into this new field of immunometabolism is shedding some light on these questions, but more research will be necessary to produce effective interventions for HFpEF patients, he added.

"Research from our lab and others is raising possibilities of therapeutic targets that need to be investigated," Dr. Hill said. "There's a reasonable chance that we could have therapies available for this intractable condition within the next decade."

Explore further

One-two punch helps solve greatest unmet need in cardiology

More information: Gabriele G. Schiattarella et al, Immunometabolic mechanisms of heart failure with preserved ejection fraction, Nature Cardiovascular Research (2022). DOI: 10.1038/s44161-022-00032-w
Citation: Dominant form of heart failure caused by metabolic-immune interaction, review article suggests (2022, March 23) retrieved 3 July 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors